Geri Dön

Cisplatin@US-tube carbon nanocapsules for enhanced chemotherapeutic delivery

Başlık çevirisi mevcut değil.

  1. Tez No: 401697
  2. Yazar: ADEM GÜVEN
  3. Danışmanlar: PROF. LON J. WILSON
  4. Tez Türü: Doktora
  5. Konular: Biyokimya, Eczacılık ve Farmakoloji, Biochemistry, Pharmacy and Pharmacology
  6. Anahtar Kelimeler: Belirtilmemiş.
  7. Yıl: 2013
  8. Dil: İngilizce
  9. Üniversite: Rice University
  10. Enstitü: Yurtdışı Enstitü
  11. Ana Bilim Dalı: Kimya Ana Bilim Dalı
  12. Bilim Dalı: Belirtilmemiş.
  13. Sayfa Sayısı: 124

Özet

Özet yok.

Özet (Çeviri)

The use of chemotherapeutic drugs in cancer therapy is often limited by problems with administration such as insolubility, inefficient biodistribution, lack of selectivelty, and inability of the drug to cross cellular barriers. To overcome these limitations, various types of drug delivery systems have been explored, and recently, carbon nanotube (CNT) materials have garnered special attention in the area. This thesis details the preparation, characterization, and in vitro and in vivo testing of a new, ultra-short single-walled carbon nanotube (US-tube)-based drug delivery system for the treatment of cancer. In particular, the encapsulation of cisplatin (CDDP), a widely-used anticancer drug, within US-tubes has been achieved by a loading procedure that is reproducible, and the resulting CDDP@US-tube material characterized by high-resolution transmission electron microscopy (HR-TEM), energy-dispersive spectroscopy (EDS), X-ray photoelectron spectroscopy (XPS), and inductively-coupled optical emission spectroscopy (ICP-OES). Dialysis studies performed in phosphate-buffered saline (PBS) at 37 °C have demonstrated that CDDP release from CDDP@US-tubes can be controlled (retarded) by wrapping the CDDP@US-tubes with Pluronic®-F108 surfactant. The anticancer activity of Pluronic-wrapped CDDP@US-tubes (W-CDDP@US-tubes) has been evaluated against two different breast cancer cell lines, MCF-7 and MDA-MB-231, and found to exhibit enhanced cytotoxicity over free CDDP. Moreover, it has been shown that CDDP release from W-CDDP@US-tubes nanocapsules can be stimulated remotely by a radiofrequency (RF) field which disrupts the Pluronic coating to release CDDP. RF-induced release-dependent cytotoxicity of W-CDDP@US-tubes has been evaluated in vitro against two different liver cancer cell lines, Hep3B and HepG2, and found to exhibit superior cytotoxicity compared to W-CDDP@US-tubes not exposed to RF. Finally, in vivo biodistribution and therapeutic efficacy of the CDDP@US-tube material has been evaluated against three different breast cancer xenograft mouse (SCID/Beige) models, and found to exhibit greater efficacy in suppressing tumor growth than free CDDP for both a MCF-7 cell line xenograft model and a BCM-4272 patient-derived xenograft (PDX) model. The CDDP@US-tubes also demonstrated prolonged circulation time compared to free CDDP which enhances permeability and retention (EPR) effects resulting in significantly more CDDP accumulation in tumors, as determined by Platinum (Pt) analysis via inductively-coupled plasma mass-spectrometry (ICP-MS).

Benzer Tezler

  1. Düşük yoğunluklu ultrasesin sisplatin ile indüklenmiş periferik nöropatideki tedavi etkinliğinin değerlendirilmesi

    Assessment of the therapeutical efficiency of low intensity ultrasound on cisplatin induced peripheral neuropathy

    BÜŞRA BİLİR YILDIZ

    Doktora

    Türkçe

    Türkçe

    2021

    BiyofizikAydın Adnan Menderes Üniversitesi

    Biyofizik Ana Bilim Dalı

    DR. ÖĞR. ÜYESİ ÖZLEM BOZKURT GİRİT

  2. Yeni imidazolidindion türevlerinin ve platin komplekslerinin insan kanser hücrelerinde anti-tümör etkilerinin araştırılması

    Investigation of the anti-tumor effects of new imidazolidinedione derivatives and platinum complexes on human cancer cells

    ESMA ERCİYAS BAYKAL

    Yüksek Lisans

    Türkçe

    Türkçe

    2021

    GenetikGebze Teknik Üniversitesi

    Moleküler Biyoloji ve Genetik Ana Bilim Dalı

    PROF. DR. TAMER YAĞCI

  3. Akciğer kanserinin alt tiplerinde ilaç etkileşim mekanizmalarının incelenmesi

    Investigation of drug interaction mechanisms in lung cancer subtypes

    MAHMUT DEMİRBİLEK

    Doktora

    Türkçe

    Türkçe

    2023

    Moleküler TıpSağlık Bilimleri Üniversitesi

    Moleküler Tıp Ana Bilim Dalı

    PROF. DR. YUSUF TUTAR

  4. Class IA PI3K isoforms lead to differential signaling downstream of PKB/AKT

    Sınıf IA PI3K izoformlarının sinyal iletimindeki özgün hedefleri

    HAZAL BERİL ÇATALAK

    Yüksek Lisans

    İngilizce

    İngilizce

    2020

    Biyokimyaİhsan Doğramacı Bilkent Üniversitesi

    Moleküler Biyoloji ve Genetik Ana Bilim Dalı

    DOÇ. DR. ONUR ÇİZMECİOĞLU